chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient having strep; This is a spontaneous report from a contactable consumer. A 15-year-old adolescent male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection; Batch/Lot number: not reported), via an unspecified route of administration on 09Jun2021 as a Dose 1, Single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that she was from Pediatrics and they have a patient who received the 1st dose of the Pfizer Biontech COVID-19 vaccine on 9Jun2021 and was due for the 2nd dose on 30Jun2021. However, they were not able to administer the 2nd dose due to the patient having strep. The reporter mentioned that the patient was taking antibiotics and that his doctor advised him not to get 2nd dose yet. The reporter said the patient came in today and wanted to know if he still qualified in receiving the 2nd shot. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
indigestion and throwing up, once they put an EKG on him they noticed he was having heart attack and was hospitalized for 3 days, he had a stint put in his right coronary artery and now takes medication,
Fatigue, headache, shooting spasms along right side, started Friday (9/24) then a  red rash started on Saturday (9/25) and has continued to worsen
Arm very sore; Tenderness in joints; Swelling in joints; Pain in the armpit; Arm very red; Arm warm to the touch; Achenes in joints; Heat in the armpit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit) and ERYTHEMA (Arm very red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit), ERYTHEMA (Arm very red), VACCINATION SITE WARMTH (Arm warm to the touch), ARTHRALGIA (Achenes in joints) and HEAT EXHAUSTION (Heat in the armpit). At the time of the report, PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit), ERYTHEMA (Arm very red), VACCINATION SITE WARMTH (Arm warm to the touch), ARTHRALGIA (Achenes in joints) and HEAT EXHAUSTION (Heat in the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Initial health care professional report received on 11 May 2010: This patient received S-OIV FLUVIRIN (batch number 1013306P) 0.5 ml dose, intramuscular on 05 May 2010, which got expired in Apr 2010. No other information was provided. Follow up report received from healthcare profession on 02 Jun 2010: The vaccination time added as 11:19 and no other new medical significant information received so it considered to be a non significant follow up.
Pt recv vax on 10/9/98; 25 min post vax pt exp dizziness, lightheaded, tingling in mouth, face& right hand, swollen tongue; pt to E.R.; tx=Prednisone &Benadryl
Two days after taking the flu I start to have shortness of breath and cold sweat for no apparent reason. These symptoms lasted for a couple of weeks from 11/30/16 until about 12/15/16. Before taking flu shot I had no issues at all. I informed the nurse that I had gotten sick in the past from flu shots (in 1985), now it is time for annual flu shots again and I am very concerned for my safety (11/01/17). I did not visit a doctor at the time of incident.
Medication error related to right medication (vaccine).The patient received moderna Vaccine (first dose on 05/26/2021) and Pfizer vaccine administered instead of Second Moderna.  There was no signs and symptoms have happened .
DOB: 07/12/1985 Dept/Mgr: Float pool (NA) Resolution of Symptoms: ongoing Covid-19 Vaccine Yes/No:  Yes      Date of last dose: 02/13/21 Notes: EE calling to report +COVID result today from 8/26/21 specimen.  EE still with congestion and cough.  Last took symptom-reducing meds 8/27.  Advised EE to quarantine for 10d from symptom onset (8/26) and to call EH back on 9/6 to report on S/S.
pain; hives are everywhere, from her shoulders to her feet, from the size of a dime to the size of an egg, belly, back, breasts, bottom, legs; face rash, like rosacea; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8734) via an unspecified route of administration at left arm on 03Apr2021 (44-year-old at time of vaccination), at single dose, for COVID-19 immunization. The patient's medical history included ongoing Hashimoto's disease (diagnosed at least 5 years ago); chronic idiopathic urticaria (history of hives, she has not had them in about 5 years). Concomitant medications included ongoing levothyroxine sodium (SYNTHROID) for Hashimoto's disease (been taking for at least 3 years). Patient state she has had her first dose of Pfizer COVID vaccine, states her next dose is scheduled on Saturday 24Apr 2021. Patient states about 2 weeks after the first dose, on 12 Apr2021, she started getting face rash, like rosacea, states that went away about 2 days later. States on 16Apr2021 she started getting hives. Patient states she does have a history of hives, clarifies she has chronic idiopathic urticaria, however, she states she has not had them in about 5 years. Patient is concerned these may be related to the first dose of the COVID vaccine, states she is trying to see if she should go for second dose or not, states she is not swelling or having trouble breathing, just trying to hear from someone that it is okay to get the second dose. Patient states the hives are everywhere, from her shoulders to her feet, from the size of a dime to the size of an egg, belly, back, breasts, bottom, legs. Patient states she is treating the hives with antihistamines, states they do not go completely away but the pain goes away. Taking Allegra, Zyrtec, and Benadryl/ all daily. The outcome of the event face rash was recovered on 15Apr2021; outcome of pain was recovered; outcome of hives was not recovered (worsened).  No follow-up attempts are needed. No further information is expected.
On 10-02-2008 the patients mother was in the health department for services and reported that patient became very ill 3 days after getting vaccine here 1/2008. She began with rash and itching on 1 leg that spread in patches all over her body. She did not have a fever. She chilled, had nausea , and was unable to eat. she had no energy. Over the course of her illness (3mo) she lost 20lbs. Shortly after onset of illness, she saw a doctor and was sent to a Dermatologist. According to the patients mother diagnosis was pseudomonas. After 3 months the patient began to have relief from symptoms and is now feeling recovered. Any treatment/ Medications is unknown to me.  12/31/08 Reviewed PCP medical records of 4/08. FINAL DX: erythema multiforme Records reveal patient experienced papular red itchy rash all over x 1 week, decreased appetite, fever & chills x 2 days. Seen in ER on 4/12 & dx w/cellulitis.  Tx w/antibiotics.  PCP dx w/EM & tx w/steroids.  RTC 4/29 w/o improvement, now w/left ear pain & 9# wt loss.  Dx w/otitis externa, treated w/ear drops & referred to Derm.  No other records available.
pt recv vax 4MAY95 & 8MAY95 pt whose BP was usually 110/70 was 140/100 & exp dizziness,h/a,fatigue & insomnia;pt recovered 19MAY95
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age. Current conditions and medical history was not reported. Between 26-OCT-2014 to 29-OCT-2014, the patients were vaccinated with ROTATEQ (dose, lot number and frequency were not reported), oral. Concomitant medications were not reported. The patients received ROTATEQ that was improperly stored. On an unknown date, ROTATEQ was exposed to 11.1 Celsius for 1 hour 18 minutes (all doses supported). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Rash started on the leg that the vaccine was given then spread to cover her entire body even her face and buttocks but not her feet. Also had a low grade fever on two days after vaccination.
Client presented to Van with mother. No shot history in computer system, client's mother brought paper shot record. Noted 4 doses of Dtap on shot record so administered a dose of Dtap. Upon returning to clinic and entering vaccines into computer system, noted a 5th dose of Dtap on shot record beneath other doses listed, which made the dose administered on the Van that day invalid. No adverse event occurred as of this report.
Normal soreness at injection site starting 6 hours post injection. 24 hours post injection painful arm with numbness notes starting at the injection site and radiating down the right arm into the fingers. Post day two lots of pain under arm area that lasted 4 days. Post day 3 started to have numbness from right arm spread across chest with chest discomfort. Numbness also felt down left arm.  This lasted until post day 9. On post day 11 started to have pain in the jaw that traveled up the face and impacted temple and eye with dull numbness, achy pain on the left side of the face. Took ibuprofen for the next 5 days to keep pain controlled. Dentist visit ruled out orthodontic issues and diagnosed neuralgia.  I was started on prednisone taper.  This same reaction happened several days after my 2nd COVID vaccine but I was having many other side effects that were more bothersome and didn?t link the issue to the vaccine. I had the Modena for my first 2 doses and due to adverse side effects got a Pfizer booster.
Serve body aches, high fever up to 104, chills, fatigued switched on and off with Tylenol & Ibuprofen.  Applied ice packs and soaked feet in cold water to get the fever down. lasted 24 hours and feeling better today 1/27/21.  Temp only 100.1 and with Tylenol 99.5 no symptoms other than slight fatigue
Patient admitted as observation on 09/26/2021 and upgraded to inpatient status on 09/27/2021 due to Rhabdomyolysis and a fall with weakness. Patient was tested for COVID-19 and was positive on 09/26/2021.
Accidentally administered expired doses to patients past the published expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Accidentally administered expired doses to patients past the published expiration date) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Accidentally administered expired doses to patients past the published expiration date). On 20-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Accidentally administered expired doses to patients past the published expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.  Number of doses/vials for lot 006C21A include 1 vial, 4 doses. The vial was initially stored in the refrigerator on 20 Oct 2021. The vial did not undergone any temperature excursions.   This case was linked to MOD-2021-365268, MOD-2021-365264 (Patient Link).
She was having muscle aches, afebrile, runny nose, congestion, sore throat, facial pain, slight productive cough, overall body pain.
Woke up the next morning with redness, warm swelling near/around injection site, present about 2 days after injection
Swelling / Pain of forearm and dorsum of the hand (occurred on the side of the shot was administered). Time course 12-15 hours of the shot. Prescription ace bandage, ice, elevation rest. Complete resolution in 72 hours.
Arm swelled double-hard bruised looking-hot to touch-knot remains. Continues sore, ice to area/Tylenol/Benadryl.
Systemic: HR as high as 160. Respiratory rate of 22. "Heavy feeling in chest" Pale color of skin-Medium; symptoms lasted 1 day
BODY ACHES; FEVER; SORE ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-MAR-2021, the subject experienced body aches. On 09-MAR-2021, the subject experienced fever. On 09-MAR-2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, body aches and sore arm was not reported. This report was non-serious. This case, from the same reporter is linked to 20210322999.
DISTENDED ABDOMEN, 102 FEVER, BODY ACHE, LOCAL INJECTION SITE ERYTHEMA, SORENESS AND WARMTH.
Patient fainted few minutes after the shot (felt dizzy), fell on the floor sustained laceration on the forehead and broke front tooth. Examined patient PR 102 O2 Sat 98%-99% chest clear bs. Heart no murmur sent to ER for further evaluation & suturing of laceration.
urinary tract infection; passed out; foggy; missed her second dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LOSS OF CONSCIOUSNESS (passed out) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Urinary tract infection (She was given some medication and has significantly improved with her urinary tract infection.) on 05-Apr-2021. Concurrent medical conditions included Stomach cancer.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced LOSS OF CONSCIOUSNESS (passed out) (seriousness criterion medically significant), FEELING ABNORMAL (foggy) and PRODUCT DOSE OMISSION ISSUE (missed her second dose). On 05-Apr-2021, the patient experienced URINARY TRACT INFECTION (urinary tract infection). On 16-Mar-2021, PRODUCT DOSE OMISSION ISSUE (missed her second dose) had resolved. At the time of the report, LOSS OF CONSCIOUSNESS (passed out) was resolving and FEELING ABNORMAL (foggy) and URINARY TRACT INFECTION (urinary tract infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Her doctor and oncologist have told her to get the vaccine 1 week from today.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Rec'd shot 9/3/15 630 became dizzy, nausea, couldn't eat dinner. 9/11/15 dizzy and nausea unable to drive lasted 4 hrs 9/12/15 severe dizzy, nausea, vomiting needed ambulance to Emer Rm. Lasted 5 hrs. 9/22 dizzy 9/23 dizzy 9/27 dizzy - lasted 3 1/2 hrs 9/28 MRI - normal (brain) 10/13 dizzy 10/18 dizzy.
Insomnia started on 9/29 and persists. Nausea and low appetite started on 9/29. Appetite returned on 9/30. Swelling in face, back of head, swelling in hands, stiff joints and achy back started on 10/3. Pressure behind the eyes and noticeable slight loss of hearing on 10/4.
Friday morning (9/25) woke up w/ soreness from knees to feet. Pain increased until Saturday. Went to E.R. and followed up w/G.P. in N.J. is having trouble walking and sleeping w/pain in knees to feet.
Fever; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingrx, the patient experienced fever.
Severe swelling (approx. 5 inches) around the vaccination area. Rash on the bottom have of infants body and high temperature 101.9 for 3 days.
Fatigue; Arm was warm; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm was warm), VACCINATION SITE PAIN (Sore arm) and FATIGUE (Fatigue) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU (Patient took the flu shot a couple of weeks ago.). Concurrent medical conditions included Arthritis (Patient received cortisone injections arthritis.). Concomitant products included RIVAROXABAN (XARELTO) for Anticoagulant therapy.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced FATIGUE (Fatigue). In February 2021, the patient experienced VACCINATION SITE WARMTH (Arm was warm) and VACCINATION SITE PAIN (Sore arm). The patient was treated with HYDROCORTISONE ACETATE (CORTISONE [HYDROCORTISONE ACETATE]) for Adverse event, at an unspecified dose and frequency; PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and AMIKACIN SULFATE (AMICAGEL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Arm was warm), VACCINATION SITE PAIN (Sore arm) and FATIGUE (Fatigue) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Among the treatment they used patient stated that Arnica gel brought some relief to her.   This case was linked to MOD-2021-395766, MOD-2021-395768 (Patient Link).
Itching and rash at site of injection. Symptoms first started 9 days after initial dose.  Rash is a little bigger today (3 days after symptoms first started).
Information has been received from a nurse concerning a 20 year old patient (gender not specified). The patient's medical history, concurrent condition and concomitant medication use were not provided. On unknown dates the patient completed the hepatitis B vaccine series (manufacturer unknown), (route unknown) for prophylaxis. The nurse reported that the patient had titers dawn (unspecified date and reason) that showed the patient had a low immune response to Hepatitis B. The 20 year old patient was administered a pediatric dose of RECOMBIVAX HB (lot#, route, total dosage and date of vaccination not specified) due to having a low immune response to Hepatitis B. No further information was provided. Additional information is not expected.
Dizziness that almost made her fall; Dizziness that almost made her fall; Fever (99,7F); This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness that almost made her fall), GAIT DISTURBANCE (Dizziness that almost made her fall) and PYREXIA (Fever (99,7F)) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035621A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Diabetes. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for Anticoagulant therapy, ANASTROZOLE (ARIMIDEX) for Cancer, METFORMIN for Diabetes.    On 02-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced DIZZINESS (Dizziness that almost made her fall), GAIT DISTURBANCE (Dizziness that almost made her fall) and PYREXIA (Fever (99,7F)). At the time of the report, DIZZINESS (Dizziness that almost made her fall), GAIT DISTURBANCE (Dizziness that almost made her fall) and PYREXIA (Fever (99,7F)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Sep-2021, Body temperature: 99.7 (High) She now she has a 99.7 F fever..         No treatment medications were reported.
SHORTNESS  OF BREATH; CHEST TIGHTNESS; NON-PRODUCTIVE COUGH; HAND  TINGLING; HEAVY ARM; PAIN IN HAND; INJECTION SITE PAIN; HEADACHE; This spontaneous report received from a patient concerned a 51 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 13:15 for prophylactic vaccination.  No concomitant medications were reported.  On 07-APR-2021, the subject experienced hand tingling. On 07-APR-2021, the subject experienced heavy arm. On 07-APR-2021, the subject experienced pain in hand. On 07-APR-2021, the subject experienced injection site pain. On 07-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced shortness of breath. On 09-APR-2021, the subject experienced chest tightness. On 09-APR-2021, the subject experienced non-productive cough. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site pain, and headache on 07-APR-2021, was recovering from heavy arm, pain in hand, and hand tingling, and had not recovered from shortness of breath, non-productive cough, and chest tightness. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Breathing issues (oxygen drops) heart attack, chronic breathing issues.  Currently in testing phase. Treated with inhaler, O2 monitor, blood pressure medication,  heart monitor.